| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029046338 |
| P356 | DOI | 10.1007/S10875-013-9879-0 |
| P698 | PubMed publication ID | 23443958 |
| P5875 | ResearchGate publication ID | 235740952 |
| P50 | author | Juan J Carrero | Q37828646 |
| Raymond Vanholder | Q55232541 | ||
| P2093 | author name string | Joris R Delanghe | |
| Marijn M Speeckaert | |||
| Reinhart Speeckaert | |||
| P2860 | cites work | Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis | Q82691213 |
| Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD | Q83726413 | ||
| Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 | Q84309344 | ||
| Changes in circulating biomarkers during a single hemodialysis session | Q84419513 | ||
| Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors | Q27687176 | ||
| Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3. | Q27690890 | ||
| Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition | Q28115835 | ||
| M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules | Q28118843 | ||
| Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation | Q29147380 | ||
| Inflammatory mechanisms in obesity | Q29617932 | ||
| The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. | Q30377280 | ||
| A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients | Q30478833 | ||
| High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study | Q31004218 | ||
| Atypical hemolytic-uremic syndrome | Q33386736 | ||
| Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3. | Q33402289 | ||
| Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus | Q33920964 | ||
| The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells | Q33927564 | ||
| Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation | Q33944773 | ||
| Human pentraxin 3 binds to the complement regulator c4b-binding protein. | Q34018825 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients | Q34083517 | ||
| PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation | Q34106947 | ||
| Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation | Q34128052 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies | Q34154838 | ||
| The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells | Q34171874 | ||
| Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. | Q34184675 | ||
| Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites | Q34380249 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients | Q34406338 | ||
| Small-vessel vasculitis | Q34445978 | ||
| Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. | Q34450228 | ||
| Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. | Q34635250 | ||
| Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. | Q34683473 | ||
| Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease | Q34724967 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Pathogen recognition by the long pentraxin PTX3. | Q35054493 | ||
| Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis | Q35133148 | ||
| Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease | Q35664554 | ||
| Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response | Q35915482 | ||
| TLR4 activation mediates kidney ischemia/reperfusion injury | Q35987574 | ||
| Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury | Q36114632 | ||
| The impact of early cytomegalovirus infection and disease in renal transplant recipients | Q36168599 | ||
| The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps | Q36209095 | ||
| The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps | Q36229261 | ||
| Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury | Q36403585 | ||
| Long pentraxin 3 in pulmonary infection and acute lung injury. | Q36727799 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| Pentraxins, humoral innate immunity and tissue injury | Q37200012 | ||
| The C-terminus of complement factor H is essential for host cell protection | Q37238656 | ||
| Pentraxins, anti-pentraxin antibodies, and atherosclerosis | Q37328097 | ||
| The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity | Q37361426 | ||
| Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. | Q37421806 | ||
| Pathogenesis of Henoch-Schönlein purpura nephritis | Q37424655 | ||
| Ischemia and reperfusion--from mechanism to translation | Q37455225 | ||
| The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. | Q37630001 | ||
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. | Q37775325 | ||
| Pentraxins in innate immunity: lessons from PTX3. | Q37777659 | ||
| The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling | Q37851153 | ||
| Recent insights in inflammation-associated wasting in patients with chronic kidney disease | Q37882287 | ||
| Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. | Q37911240 | ||
| Leucocyte recruitment in inflammation and novel endogenous negative regulators thereof | Q38009359 | ||
| Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity | Q39477901 | ||
| Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors. | Q39505438 | ||
| Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. | Q39623053 | ||
| Systemic sclerosis. A vascular perspective | Q40922429 | ||
| Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system | Q42584975 | ||
| Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. | Q43179135 | ||
| Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome | Q43181277 | ||
| Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients | Q44456570 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients. | Q44647322 | ||
| Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis | Q45247216 | ||
| Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia | Q45445071 | ||
| DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. | Q46515698 | ||
| Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization | Q46788898 | ||
| Killing by neutrophil extracellular traps: fact or folklore? | Q47236853 | ||
| The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients | Q47848978 | ||
| PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion | Q48786237 | ||
| Genetic variation in pentraxin (PTX) 3 gene associates with PTX3 production and fertility in women. | Q51608111 | ||
| Regulation of leukocyte recruitment by the long pentraxin PTX3. | Q51774594 | ||
| Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus. | Q51824335 | ||
| Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis. | Q53141150 | ||
| Pentraxin-3 expression in acute renal allograft rejection. | Q53158989 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. | Q53496784 | ||
| Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
| PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. | Q54454087 | ||
| Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury | Q56942220 | ||
| IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus | Q56942458 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction | Q56942653 | ||
| Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice | Q56942821 | ||
| Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN- | Q56942888 | ||
| Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients | Q57750433 | ||
| Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients | Q59510781 | ||
| A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients | Q73152669 | ||
| Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta | Q73669745 | ||
| Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease | Q80316793 | ||
| Markers of inflammation before and during peritoneal dialysis | Q82456915 | ||
| Inflammation markers, chronic kidney disease, and renal replacement therapy | Q82456920 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 881-890 | |
| P577 | publication date | 2013-02-27 | |
| P1433 | published in | Journal of Clinical Immunology | Q6294961 |
| P1476 | title | Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease | |
| P478 | volume | 33 |
| Q38858633 | Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q64104744 | Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies |
| Q55455847 | Exogenous pentraxin-3 inhibits the reactive oxygen species-mitochondrial and apoptosis pathway in acute kidney injury. |
| Q56942132 | PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis |
| Q40162622 | Pentraxin 3 as a clinical marker in children with lower respiratory tract infection. |
| Q42068957 | Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. |
| Q36557903 | Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia. |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q55447799 | Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model. |
| Q48193738 | The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis |
| Q26740125 | Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease |
Search more.